DNA VACCINES
Smarter DNA Vaccine Development Starts with dbDNA™
dbDNA™ is a high-purity, enzymatically produced vector designed to streamline DNA vaccine development. With improved gene delivery and enhanced expression, it offers a cleaner, faster route from concept to clinic, supporting effective and scalable immunisation strategies.
OVERVIEW
Enhancing your DNA vaccine development with scalable, high-purity technology.
Rapid scale up
Fast scale up and scale out for high volume indications and personalised medicine
Improved Immunogenicity
dbDNA™ shows improved immunogenicity and dose sparing vs pDNA
1
DNA vaccine candidate
The benefits of DNA vaccines in your workflow
dbDNA™ enables safe, scalable vaccine production with optimised gene expression and superior regulatory compliance.
Enhanced gene expression for improved immune response.
Eliminates bacterial sequences for genetic delivery.
Streamlined production for rapid research timelines.
Scalable production for clinical applications.
GMP-compliant material
Optimised vector performance for vaccine development.
Touchlight vs competitors
Our technology offers improvements in the efficiency, purity, and scalability of your processes compared to conventional plasmid DNA methods, ensuring optimised vaccine production.
RESOURCES
Discover dbDNA™ and its role in DNA vaccine development
Explore our latest research and insights into enzymatic DNA innovation and how it enhances your DNA vaccine production for next-generation immunotherapy.
